Buscar
Mostrando ítems 1-10 de 13
Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-To-head trials in acute major depression: Systematic review and meta-Analysis
(Sage Publications, 2017)
BACKGROUND:
A comparison across trials conducted over several decades suggested superior efficacy of tricyclic antidepressants (TCAs) over selective serotonin-reuptake inhibitors (SSRIs). However, this outcome may reflect ...
Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-To-head trials in acute major depression: Systematic review and meta-Analysis
(Sage Publications, 2017)
BACKGROUND:
A comparison across trials conducted over several decades suggested superior efficacy of tricyclic antidepressants (TCAs) over selective serotonin-reuptake inhibitors (SSRIs). However, this outcome may reflect ...
Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
(2020)
Background: Efforts to develop less heterogeneous, more clinically useful diagnostic categories for depressive disorders include renewed interest in the
concept of melancholia (Mel). However, clinical or biological ...
Emprego da eletroextração multifásica para extração de antidepressivos tricíclicos em fluido oral e determinação por UHPLC-MS/MS e PS-MS
(Universidade Federal de Minas GeraisBrasilICX - DEPARTAMENTO DE QUÍMICAPrograma de Pós-Graduação em QuímicaUFMG, 2020-02-27)
Tricyclic antidepressants (TCAs) are substances used for the treatment of anxiety disorders and depression. And despite its effectiveness, have many side effects. Due to this and also to narrow therapeutic window of these ...
Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms
(Pergamon-Elsevier Science Ltd, 2018-07)
The activity of tricyclic antidepressants (TCAs) at α7 and α9α10 nicotinic acetylcholine receptors (AChRs) as well as at hippocampal α7-containing (i.e., α7*) AChRs is determined by using Ca 2+ influx and electrophysiological ...
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
(LIBRAPHARM, 2006-09)
Objective: To summarize remission rates and dropouts due to adverse drug reactions (ADRs) or lack of efficacy (LoE) of serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin-reuptake inhibitors (SSRIs), ...
The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: Cost-effectiveness and budget-impact analyses
(Adis International Ltd, 2007)
Objective: To determine the cost effectiveness, from the Brazilian Ministry of Health viewpoint, of three antidepressant classes for major depressive disorder (MDD), and the budget impact of introducing serotonin-noradrenaline ...
Consumption of antidepressants in Chile from 1992 to 2004 Consumo de antidepresivos en Chile entre 1992 y 2004
(2008)
Background: Data from the Mnistry of Health show that in Chile in 2004, 17% of the population had some form of depresdon and mood disorders are the tenth cause of disability-adjusted life years (DALY) loss. Aim: To determine ...
The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary - Cost-effectiveness and budget-impact analyses
(ADIS INT LTD, 2007)
Objective: To determine the cost effectiveness, from the Brazilian Ministry of Health viewpoint, of three antidepressant classes for major depressive disorder (MDD), and the budget impact of introducing serotonin-noradrenaline ...
Consumption of antidepressants in Chile from 1992 to 2004 / Consumo de antidepresivos en Chile desde 1992 hasta 2004
(SOC MEDICA SANTIAGO, 2008-09)
Background: Data from the Ministry of Health show that in Chile in 2004, 17% of the population had some form of depression and mood disorders are the tenth cause of disability-adjusted life years (DALY) loss. Aim: To ...